CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: Treatment of Moderate to Severe Glabellar Lines [Phase 3]

Phase 3 trial update for treatment of moderate to severe glabellar lines has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED | Results posted: 2023-06-18